Pricing Log in Create free account

Nutriband Inc. (NTRB) vs Promis Neurosciences (PMN)

Nutriband Inc. and Promis Neurosciences are both Biotechnology companies. Nutriband Inc. and Promis Neurosciences are of similar size ($78.0M and $76.2M). Promis Neurosciences grew revenue faster over the last twelve months: 450.0% against −37.3%. Promis Neurosciences has the higher net margin (0.00% vs −430.4%) and the higher return on invested capital (0.00% vs −227.9%). Across the 17 metrics below, Promis Neurosciences leads on 9 and Nutriband Inc. on 8.

Valuation

Metric NTRB PMN Biotechnology median
P/E n/m n/m 8.50
P/S 46.74 33,868.44 9.71
P/B 14.20 1.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 44.68 11,382.03 9.21
Earnings yield (9.21%) (155.70%) (33.15%)
Free cash flow yield (4.81%) (56.51%) (25.50%)

Profitability

Metric NTRB PMN Biotechnology median
Gross margin 33.14% 0.00% 65.16%
Operating margin (435.57%) 0.00% 0.00%
Net margin (430.43%) 0.00% 0.00%
Free cash flow margin (224.54%) 0.00% 0.00%
Return on equity (100.79%) (172.30%) (56.36%)
Return on assets (84.56%) (127.57%) (48.04%)
Return on invested capital (227.92%) 0.00% 0.00%

Growth

Metric NTRB PMN Biotechnology median
Revenue growth (TTM) (37.25%) 450.00% 6.02%
EPS growth (last fiscal year) (160.61%) (922.18%) 30.26%
Revenue growth, 5-year CAGR 16.63% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NTRB PMN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.21 7.85 4.72
Net debt to EBITDA 0.56 0.15 0.96

Dividend

Metric NTRB PMN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NTRB PMN Biotechnology median
Market cap 76.21m 78.02m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack